Cargando…
Molecular biomarkers for facilitating genome‑directed precision medicine in gynecological cancer (Review)
Prominent recent advancements in cancer treatment include the development and clinical application of next-generation sequencing (NGS) technologies, alongside a diverse array of novel molecular targeting therapeutics. NGS has enabled the high-speed and low-cost sequencing of whole genomes in individ...
Autores principales: | Minaguchi, Takeo, Shikama, Ayumi, Akiyama, Azusa, Satoh, Toyomi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472042/ https://www.ncbi.nlm.nih.gov/pubmed/37664647 http://dx.doi.org/10.3892/ol.2023.14012 |
Ejemplares similares
-
Preoperative Venous Thromboembolism Screening and Postoperative Selective Anticoagulant Therapy Effectively Prevents Postoperative Symptomatic Venous Thromboembolism in Gynecological Malignancies: A 15-Year, Single-Center Study
por: Tasaka, Nobutaka, et al.
Publicado: (2023) -
Cellular angiofibroma in the retroperitoneal space during pregnancy: A case report
por: Abe, Hanae, et al.
Publicado: (2023) -
Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma
por: Akiyama, Azusa, et al.
Publicado: (2019) -
Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer
por: Nakao, Sari, et al.
Publicado: (2020) -
PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas
por: Zhang, Shuang, et al.
Publicado: (2020)